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We report on a 9-years-old patient with mild intellectual disability, facial dimorphisms, bilateral semicircular canal
dysplasia, periventricular nodular heterotopias, bilateral hippocampal malrotation and abnormal cerebellar foliation,
who developed mild motor impairment and gait disorder due to a pilocytic astrocytoma of the spinal cord.
Array-CGH analysis revealed two paternal inherited chromosomal events: a 484.3 Kb duplication on chromosome
15q26.3 and a 247 Kb deletion on 22q11.23. Further, a second de novo 1.5 Mb deletion on 22q11.21 occurred.
Chromosome 22 at q11.2 and chromosome 15 at q24q26 are considered unstable regions subjected to copy
number variations, i.e. structural alterations of genome, mediated by low copy repeat sequences or segmental
duplications. The link between some structural CNVs, which compromise fundamental processes controlling
DNA stability, and genomic disorders suggest a plausible scenario for cancer predisposition.
Evaluation of the genes at the breakpoints cannot account simultaneously for the phenotype and tumour
development in this patient. The two paternal inherited CNVs arguably are not pathogenic and do not
contribute to the clinical manifestations. Similarly, although the de novo large deletion at 22q11.21 overlaps with
the Di George (DGS) critical region and results in haploinsufficiency of genes compromising critical processes
for DNA stability, this case lacks several hallmarks of DGS.
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Patients harbouring deletions within chromosome 22q11
present a wide array of clinical phenotypes, including
DiGeorge, Velo-Cardio-Facial (DGS/VCFS) or 22q11.2
deletion syndrome [1-3]. Few reports of malignancy in
patients with 22q11.2 deletion syndrome exist, including
kidney tumours, hepatoblastomas, neuroblastomas, lymph-
omas, and, very rarely, central nervous system (CNS) tu-
mours [4-7]. About 97% of DGS/VCFS patients have either
a ~3 Mb deletion or, less commonly, a smaller ~1.5 Mb
nested deletion [MIM 188400] [1]. Indeed, the long arm of
chromosome 22 at band q11.2 is one of the most unstable
regions with eight different specific low-copy repeats, des-
ignated LCR22s (LCR22-A-LCR22-H), which can yield* Correspondence: SamanthaMascelli@ospedale-gaslini.ge.it
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unless otherwise stated.recurrent Copy Number Variants (CNVs), such as micro-
deletions and microduplications [8]. A similar unstable re-
gion is present even on chromosome 15 at band q24q26
[9]. While the significance of CNVs to human path-
ology is being recognized, it is unclear how common
or functionally relevant CNVs are to the process of
carcinogenesis [10].
We present the clinical features of a 9-years-old male
harbouring two paternally inherited events – a short
22q11.23 deletion and a 15q26.3 duplication – and a de
novo 1.5 Mb deletion at 22q11.2 band. The child devel-
oped a spinal cord pilocytic astrocytoma (PA) [11-13].
We previously reported the cytogenetic characterization
of the child and his family, suggesting that parental
microdeletions/duplications could predispose to the for-
mation of de novo pathogenically distinct CNVs in off-
spring [14]. Herein, we attempt to correlate the multiplel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Patient’s clinical history, including information on family
pedigree, and cytogenetic findings were previously re-
ported (Figure 1) [14].
The child came to our attention at the age of 9 years,
after a 3-year history of gait disturbance and right leg pain
initially responding to anti-inflammatory therapy. Neuro-
logical examination revealed pes cavus, motor clumsiness,
gait abnormalities with toe-walking and positive heel
walk test. Somato-sensory evoked potentials showed
low-amplitude potentials in lower limbs. Psychomet-
rics confirmed mental retardation (Raven’s Matrices,
PM47 = 20th percentile). Electroencephalography was un-
remarkable. Mild obesity with increased abdominal fatFigure 1 Clinical features of the proband and family pedigree. (a) In t
square and an arrow - bold cross within square (II-7) indicates the second
(II-1) indicate second degree relatives who died for tumour under 55 ye
for the patient - NA indicates no chromosomal abnormalities. (b, c) The patiedistribution was present. Ophthalmologic examination
was normal, while audiometric tests revealed left con-
ductive hearing loss. Cardiac or urologic malformations
were absent, as well as immune deficiency or congenital
hypocalcaemia.
Neuroimaging and pathological examination
Spine magnetic resonance imaging (MRI) revealed en-
largement of the inferior dorsal spinal cord due to a solid
tumour, hypointense on T1-weighted images and hyperin-
tense on T2-weighted images, with mild, inhomogeneous
contrast enhancement. Leptomeningeal invasion and dis-
semation were absent (Figure 2a, b). Brain MRI showed
small nodules of subependymal gray matter heterotopia,
bilateral hippocampal malrotation, and abnormal cerebel-
lar foliation (Figure 2c, d). Temporal bone computerized
tomography revealed bilateral digenesis of the lateral
semicircular canals and vestibules forming a single cavityhe family pedigree the propositus (IV-1) is indicated by a full-black
degree uncle with pes cavus - black corner of square (II-4) and circle
ars - black corner of circle (I-6) indicate a second degree aunt informative
nt presented mild facial dimorphisms.
Figure 2 Craniospinal MRI (a-d) and temporal bone CT (e) images. Spine MRI reveals a solid tumour mass hyper intense on sagittal T2-weighted
images (a, white arrows) with mild and inhomogeneous contrast enhancement on Gd-enhanced sagittal T1-weighted images (b, black arrowheads).
Brain MRI axial STIR show bilateral frontal periventricular nodules of gray matter heterotopias (c, black arrowheads) and an area of abnormal cerebella
foliation (d, white arrowhead). Temporal bone CT scan depicts bilateral digenesis of the lateral semicircular canals and vestibules forming a
single cavity with normal appearing cochleae (e, black arrows).
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chronic otitis media were found.
After a period of surveillance, the patient underwent
neurosurgical intervention. The absence of a cleavage
plane between the tumour and the surrounding tissue
hampered total or subtotal resection, due to high risk of
functional damage. Therefore, only a biopsy was per-
formed. Histological findings were consistent with PA.
The labelling index, as evaluated by the monoclonal
antibody Ki67-MIB-1, was 1%. No expression of p53
protein was found.
Adjuvant therapies were planned to be introduced just
in case of clinical and/or imaging worsening. After four
years, the child is neurologically stable with no remark-
able change in tumour volume.
CNV analysis
CNVs were analyzed using UCSC Genome Browser
(http://www.genome.ucsc.edu) and Decipher Database
(http://decipher.sanger.ac.uk/, version 6.0) website tools.
The 15q26.3 duplication, with proximal breakpoints be-
tween base pairs 100,051,182 and 100,996,155, involved
myocyte enhancer factor 2A (MEF2A) [MIM 600660], a
target of ERK/MAPK pathway. Defects in this gene were
reported in autosomal dominant coronary artery disease 1
with myocardial infarction (ADCAD1) [MIM 608320]. The
duplication also involved putative peptidoglycan-binding
domain containing 4 (LYSMD4) [XM_005254863], ADAMmetallopeptidase with thrombospondin type 1 motif, 17
(ADAMTS17) [DQ_217943] and interrupted ceramide syn-
thase 3 (CERS3) [MIM 615276]. Mutations in ADAMTS17
can cause autosomal recessive Weill-Marchesani-like syn-
drome [MIM 613195] while alteration of both ADAMTS17
and CERS3 have been associated with autosomal recessive
congenital ichthyosis 9 (ARCI9) [MIM 615023].
The 22q11.23 deletion (chr22:25,664,618-25,911,651),
involving low density lipoprotein receptor-related pro-
tein 5-like (LRP5L) [NM_182492], has never been asso-
ciated with any disease.
The de novo 22q11.21 deletion (chr22:18,894,835-
20,311,763) involved 24 genes located within the DGS
critical region (DGCR). Besides T-box 1 (TBX1), a tran-
scription factor regulating developmental processes, several
genes are involved, as clathrin, heavy chain-like 1 (CLTCL1)
[MIM 601273], RAN binding protein 1 (RANBP1) [MIM
601180], histone cell cycle regulator (HIRA) [MIM 600237],
cell division cycle 45 (CDC45) [MIM 603465], and catechol-
O-methyltransferase (COMT) [MIM 116790] partially over-
lapping thioredoxin reductase 2 (TXNRD2) [MIM 606448].
These genes are active in many cellular processes, including
cell cycle progression, senescence, signal transduction, apop-
tosis and gene regulation.
Discussion
Locus-specific rates of CNV formation underlie not just
rare complex disorders involving multiple congenital
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cancer predisposition. The principal models currently
invoked to explain genomic instability and susceptibil-
ity to cancer, conjecture the deleterious consequences
of some structural CNVs on fundamental processes, in-
cluding DNA replication and damage response (DDR) pro-
cesses [8,15].
The child paternally inherited the 15q26.3 duplication.
This distal duplication involved four genes active in sev-
eral cellular processes encompassing MEF2A which is a
target of ERK/MAPK pathway. Although the pathway
plays an important role in PA [16], defects in MEF2A
have never been associated to this tumour. On the other
hand, paternally inherited 22q11.23 short deletion arguably
contribute neither to clinical phenotype nor to tumour
development.
The present case had a de novo 1.5 Mb deletion at
chromosome 22q11.21 (Figure 1a), one of the most
rearrangement-prone regions in the human genome as-
sociated with genetic disorders including DGS/VCFS.
Breakpoints analysis revealed that the heterozygous
deletion contains several genes of the critical region for
DGS/VCFS, i.e. several DGCRs, encompassing TBX1,
who is responsible for most of malformations of this
syndrome [17]. Twenty-four genes resulted haploinsuffi-
cient including cell division cycle 45 (CDC45), catechol-
O-methyltransferase (COMT) and thioredoxin reductase
2 (TXNRD2) which could increase risk of malignancy in
patients with 22q11.2 DS [4,8,18].
Although 22q11.21 deletion overlaps with the DGS/
VCFS region [2], the clinical phenotype was only par-
tially related with this syndrome making untangling
genotype-phenotype relationship difficult. In fact, several
hallmarks of 22q11 deletion syndrome lacked, such as
palatal abnormalities, immuno-deficiency, cardiac and
genitourinary malformations, and hypocalcaemia [2,3].
However, the patient presented motor and language
delay with behavioural immaturity consistent with the
DGS/VCFS “neurobehavioral” phenotype [18,19]. The
child additionally had periventricular gray matter het-
erotopias, hippocampal malrotation and cerebellar foli-
ation abnormalities. Brain malformations are frequent in
DGS/VCFS patients, including polymicrogyria, callosal
agenesis and cerebellar vermian hypoplasia (Figure 2c, d)
[20]. Intriguingly, bilateral inner ear malformations were
found, consisting in bilateral semicircular canal dysplasia
(Figure 2e). This abnormality has been occasionally de-
scribed in DGS/VCFS [21], but its clinical significance is
unknown due to the lack of correlation with sensor-neural
hearing loss.
This child developed a spinal cord PA (WHO grade I)
at the age of 9 years. This rare neoplasm accounts for
2-5% of all CNS tumours in children and young adults
[12,13]. PA may be encountered in tumour syndromeslike Neurofibromatosis type 1 [22] and, rarely, Frasier
and Noonan syndromes [23,24].
Only sporadic cases of brain tumour in children with
22q11 deletion syndrome were reported [5-7]. Indeed,
cytogenetic studies demonstrated the association between
CNS rhabdoid tumors and chromosome 22q11.2 alter-
ations, with SMARCB1 [MIM 601607] deletions and/or
mutations [7], while the first case of pleomorphic xanthoas-
trocytoma in a 16 year-old patient with DGS/VCFS, har-
bouring V600E BRAF mutation has been recently reported
[6]. The identified 22q11.2 deletion was proximal and did
not encompass SMARCB1 locus.
The combination of 22q11.1 deletion with a proximal
15q11.2-q13.3 duplication was described, in a case with
psychomotor delay, mild facial dysmorphisms, learning
difficulties, but without tumour [25].
This spinal PA likely represent a sporadic event and
relationship with DGS/VCFS is uncertain. Thus, despite
extent of the de novo deletion at 22q11.2 and little con-
tribution of the paternal inherited CNVs, no features ap-
parently correlated with either tumour development or
phenotypic defects. Accordingly, the possibility of the oc-
currence of the spinal tumour merely by chance should be
considered.
Conclusion
Paternal inherited CNVs did not lead to pathological
consequences. Even no consistent genotype-phenotype
correlation has been shown for the 22q11.21 deletion: a
definite link between tumour and chromosomal event
does not exist. Perhaps the de novo, large 22q11.21 dele-
tion, apparently together with the inherited benign vari-
ants, may contribute to development of both spinal PA
and complex phenotype.
These novel observations warrant ongoing reporting of
similar cases to untangle the complex genotype-phenotype
relationship with constitutional 22q11.2 deletion. The bio-
logical consequences and the contribution to cancer predis-
position of chromosomal rearrangements involving CNVs
of some DDR components deserve in-depth investigation.
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